<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39380036</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-422X</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>Virology journal</Title><ISOAbbreviation>Virol J</ISOAbbreviation></Journal><ArticleTitle>Clinical symptoms, comorbidities and health outcomes among outpatients infected with the common cold coronaviruses versus influenza virus.</ArticleTitle><Pagination><StartPage>251</StartPage><MedlinePgn>251</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">251</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12985-024-02524-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Common cold coronaviruses (ccCoVs) and influenza virus are common infectious agents causing upper respiratory tract infections (RTIs). However, clinical symptoms, comorbidities, and health effects of ccCoV infection remain understudied.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective study evaluated 3,935 outpatients with acute upper RTI at a tertiary teaching hospital. The presence of ccCoV and influenza virus was determined by multiplex molecular assay. The demographic, clinical symptoms, and health outcomes were compared between patients with ccCoV (n = 205) and influenza (n = 417) infections. Multivariable logistic regression was employed to evaluate predictors and health outcomes over a one-year follow-up.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Sore throat, nasal discharge, headache, and myalgia were more predominant in ccCoV infection; fever was common in influenza. Most patients reported moderate symptoms severity (49.8% ccCoV, 56.1% influenza). Subsequent primary care visits with symptoms of RTI within a year were comparable for both infections (27.3% ccCoV vs. 27.6% influenza). However, patients with influenza reported increased primary care visits for non-RTI episodes and all-cause hospital admission. Baseline comorbidities were associated with increased primary care visits with symptoms of RTI in either ccCoV (adjusted odds ratio [aOR] 2.5; 95% confidence interval [CI] 1.1-5.9; P = 0.034) or influenza (OR 1.9; 95% CI 1.1-3.1; P = 0.017) infections, due probably to the dysregulation of the host immune response following acute infections. In patients infected with influenza infection, dyslipidemia was a predictor for subsequent primary care visits with symptoms of RTI (unadjusted OR 1.8; 95% CI 1.0-3.0; P = 0.040).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Both influenza and ccCoV infection pose significant disease burden, especially in patients with comorbidities. The management of comorbidities should be prioritized to mitigate poor health outcomes in infected individuals.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Iyadorai</LastName><ForeName>Thevambiga</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Sin How</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Pui Li</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sii</LastName><ForeName>Hoe Leong</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P'ng</LastName><ForeName>Chun Keat</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ee</LastName><ForeName>Soon Sean</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Maw Pin</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanafi</LastName><ForeName>Nik Sherina</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Department of Primary Care Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Kim Tien</ForeName><Initials>KT</Initials><AffiliationInfo><Affiliation>Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chook</LastName><ForeName>Jack Bee</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, School of Medical and Life Sciences, Sunway University, Bandar Sunway, Selangor Darul Ehsan, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takebe</LastName><ForeName>Yutaka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>AIDS Research Center, National Institute of Infectious Diseases, Toyama, Shinjuku-ku, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Kok-Gan</ForeName><Initials>KG</Initials><AffiliationInfo><Affiliation>Division of Genetics and Molecular Biology, Institute of Biological Sciences, Faculty of Science, Universiti Malaya, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jeffrey Cheah School of Medicine and Heath Sciences, Monash University Malaysia, Bandar Sunway, Selangor Darul Ehsan, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Sarbhan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Biomedical Epidemiology Unit, Special Resource Centre, Institute for Medical Research, Ministry of Health, Shah Alam, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sam</LastName><ForeName>I-Ching</ForeName><Initials>IC</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tee</LastName><ForeName>Kok Keng</ForeName><Initials>KK</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia. k2tee@um.edu.my.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences, School of Medical and Life Sciences, Sunway University, Bandar Sunway, Selangor Darul Ehsan, Malaysia. k2tee@um.edu.my.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>FRGS/1/2020/SKK0/UM/02/17</GrantID><Agency>Ministry of Higher Education, Malaysia</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Virol J</MedlineTA><NlmUniqueID>101231645</NlmUniqueID><ISSNLinking>1743-422X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003139" MajorTopicYN="Y">Common Cold</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="Y">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010045" MajorTopicYN="Y">Outpatients</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009975" MajorTopicYN="N">Orthomyxoviridae</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017934" MajorTopicYN="N">Coronavirus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062606" MajorTopicYN="N">Tertiary Care Centers</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical symptom</Keyword><Keyword MajorTopicYN="N">Common cold coronaviruses</Keyword><Keyword MajorTopicYN="N">Comorbidity</Keyword><Keyword MajorTopicYN="N">Disease burden</Keyword><Keyword MajorTopicYN="N">Influenza virus</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>23</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39380036</ArticleId><ArticleId IdType="pmc">PMC11462790</ArticleId><ArticleId IdType="doi">10.1186/s12985-024-02524-6</ArticleId><ArticleId IdType="pii">10.1186/s12985-024-02524-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jin X, Ren J, Li R, et al. Global burden of upper respiratory infections in 204 countries and territories, from 1990 to 2019. EClinicalMedicine. 2021;37:100986.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8343248</ArticleId><ArticleId IdType="pubmed">34386754</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang JW, Lam TT, Zaraket H, et al. Global epidemiology of non-influenza RNA respiratory viruses: data gaps and a growing need for surveillance. Lancet Infect Dis. 2017;17(10):e320–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164797</ArticleId><ArticleId IdType="pubmed">28457597</ArticleId></ArticleIdList></Reference><Reference><Citation>Morens DM, Fauci AS. Emerging pandemic diseases: how we got to COVID-19. Cell. 2020;182(5):1077–92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7428724</ArticleId><ArticleId IdType="pubmed">32846157</ArticleId></ArticleIdList></Reference><Reference><Citation>Ljubin-Sternak S, Meštrović T, Lukšić I, Mijač M, Vraneš J. Seasonal coronaviruses and other neglected respiratory viruses: a global perspective and a local snapshot. Front Public Health. 2021;9:691163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8287126</ArticleId><ArticleId IdType="pubmed">34291031</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntosh K, Perlman S, Monto A, Englund JA. Perspective: a proposal to name four coronaviruses of limited virulence common cold coronaviruses. J Infect Dis. 2022;226(12):2047–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9494316</ArticleId><ArticleId IdType="pubmed">36052654</ArticleId></ArticleIdList></Reference><Reference><Citation>Mimura W, Ishiguro C, Fukuda H. Influenza vaccine effectiveness against hospitalization during the 2018/2019 season among older persons aged ≥ 75 years in Japan: the LIFE-VENUS study. Vaccine. 2022;40(34):5023–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">35851488</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes-Silva C, Vilares AT, Schweitzer V, et al. Non-COVID-19 respiratory viral infection. Breathe (Sheff). 2022;18(1):210151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9584593</ArticleId><ArticleId IdType="pubmed">36338246</ArticleId></ArticleIdList></Reference><Reference><Citation>Yale SH, Liu K. Echinacea purpurea Therapy for the treatment of the Common Cold: a Randomized, Double-blind, placebo-controlled clinical trial. Arch Intern Med. 2004;164(11):1237–41.</Citation><ArticleIdList><ArticleId IdType="pubmed">15197051</ArticleId></ArticleIdList></Reference><Reference><Citation>Zitter JN, Mazonson PD, Miller DP, Hulley SB, Balmes JR. Aircraft Cabin Air Recirculation and symptoms of the Common Cold. JAMA. 2002;288(4):483–6.</Citation><ArticleIdList><ArticleId IdType="pubmed">12132979</ArticleId></ArticleIdList></Reference><Reference><Citation>Stellrecht KA. In: Coleman WB, Tsongalis GJ, editors. Chapter 11 - molecular testing for respiratory viruses. Diagnostic Molecular Pathology: Academic; 2017. pp. 123–37.</Citation></Reference><Reference><Citation>Feldman AS, Hartert TV, Gebretsadik T, et al. Respiratory severity score separates upper versus lower respiratory tract infections and predicts measures of disease severity. Pediatr Allergy Immunol Pulmonol. 2015;28(2):117–20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4491158</ArticleId><ArticleId IdType="pubmed">26155369</ArticleId></ArticleIdList></Reference><Reference><Citation>VanWormer JJ, Sundaram ME, Meece JK, Belongia EA. A cross-sectional analysis of symptom severity in adults with influenza and other acute respiratory illness in the outpatient setting. BMC Infect Dis. 2014;14:231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4013802</ArticleId><ArticleId IdType="pubmed">24884932</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhary ML, Anand SP, Tikhe SA, et al. Comparison of the conventional multiplex RT-PCR, real time RT-PCR and Luminex xTAG® RVP fast assay for the detection of respiratory viruses. J Med Virol. 2016;88(1):51–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7166673</ArticleId><ArticleId IdType="pubmed">26100490</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafer JL. Analysis of incomplete Multivariate Data. CRC; 1997.</Citation></Reference><Reference><Citation>Cohen R, Babushkin F, Geller K, Finn T. Characteristics of hospitalized adult patients with laboratory documented influenza A, B and respiratory syncytial virus - a single center retrospective observational study. PLoS ONE. 2019;14(3):e0214517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6438521</ArticleId><ArticleId IdType="pubmed">30921408</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamata K, Thein KN, Di Ja L, et al. Clinical manifestations and outcome of viral acute lower respiratory infection in hospitalised children in Myanmar. BMC Infect Dis. 2022;22(1):350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8992414</ArticleId><ArticleId IdType="pubmed">35395744</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden FG, deJong MD. Human influenza: pathogenesis, clinical features, and management. Textbook Influenza, 2013:371–91.</Citation></Reference><Reference><Citation>Lee N, Wong CK, Hui DS, et al. Role of human toll-like receptors in naturally occurring influenza A infections. Influenza Other Respir Viruses. 2013;7(5):666–75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5781199</ArticleId><ArticleId IdType="pubmed">23552014</ArticleId></ArticleIdList></Reference><Reference><Citation>Adivitiya, Kaushik MS, Chakraborty S, Veleri S, Kateriya S. Mucociliary respiratory epithelium integrity in molecular defense and susceptibility to pulmonary viral infections. Biology (Basel). 2021;10(2):95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7911113</ArticleId><ArticleId IdType="pubmed">33572760</ArticleId></ArticleIdList></Reference><Reference><Citation>Bustamante-Marin XM, Ostrowski LE. Cilia and mucociliary clearance. Cold Spring Harb Perspect Biol. 2017;9(4):a028241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5378048</ArticleId><ArticleId IdType="pubmed">27864314</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu NH, Yang W, Beineke A, et al. The differentiated airway epithelium infected by influenza viruses maintains the barrier function despite a dramatic loss of ciliated cells. Sci Rep. 2016;6:39668.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5177954</ArticleId><ArticleId IdType="pubmed">28004801</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrew MK, Gilca V, Waite N, Pereira JA. Examining the knowledge, attitudes and experiences of Canadian seniors towards influenza (the EXACT survey). BMC Geriatr. 2019;19(1):178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6595620</ArticleId><ArticleId IdType="pubmed">31242850</ArticleId></ArticleIdList></Reference><Reference><Citation>Atamna A, Babich T, Froimovici D, et al. Morbidity and mortality of respiratory syncytial virus infection in hospitalized adults: comparison with seasonal influenza. Int J Infect Dis. 2021;103:489–93.</Citation><ArticleIdList><ArticleId IdType="pubmed">33249288</ArticleId></ArticleIdList></Reference><Reference><Citation>Edridge AWD, Kaczorowska J, Hoste ACR, et al. Seasonal coronavirus protective immunity is short-lasting. Nat Med. 2020;26(11):1691–3.</Citation><ArticleIdList><ArticleId IdType="pubmed">32929268</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Jiang L, Xu Y, et al. Epidemiology of influenza virus reinfection in Guangxi, China: a retrospective analysis of a nine-year influenza surveillance data: characteristics of influenza virus reinfection. Int J Infect Dis. 2022;120:135–41.</Citation><ArticleIdList><ArticleId IdType="pubmed">35477049</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackerson B, Tseng HF, Sy LS, et al. Severe morbidity and mortality associated with respiratory syncytial virus versus influenza infection in hospitalized older adults. Clin Infect Dis. 2019;69(2):197–203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6603263</ArticleId><ArticleId IdType="pubmed">30452608</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarin G, Lo KB, Bhargav R, et al. Factors associated with hospital readmissions among patients with COVID-19: a single-center experience. J Med Virol. 2021;93(9):5582–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8242904</ArticleId><ArticleId IdType="pubmed">34042189</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region. Italy JAMA. 2020;323(16):1574–81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7136855</ArticleId><ArticleId IdType="pubmed">32250385</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934–43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7070509</ArticleId><ArticleId IdType="pubmed">32167524</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramphul K, Lohana P, Ramphul Y, et al. Hypertension, diabetes mellitus, and cerebrovascular disease predispose to a more severe outcome of COVID-19. Arch Med Sci. 2021;6:e30–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8117084</ArticleId><ArticleId IdType="pubmed">34027212</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai T, Wu X, Zhang N, Huang X, Zhan Q. Inflammatory risk factors for hypertriglyceridemia in patients with severe influenza. J Int Med Res. 2020;48(8):300060520918058.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7871290</ArticleId><ArticleId IdType="pubmed">32776792</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng JC, Standiford TJ. Interleukin-10. Encyclopedia of Respiratory Medicine (Second Edition). Oxford: Academic Press, 2022:295–302.</Citation></Reference><Reference><Citation>Zhao Y, Qin L, Zhang P, et al. Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease. JCI Insight. 2020;5(13):e139834.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7406242</ArticleId><ArticleId IdType="pubmed">32501293</ArticleId></ArticleIdList></Reference><Reference><Citation>Dangi T, Palacio N, Sanchez S et al. Cross-protective immunity following coronavirus vaccination and coronavirus infection. J Clin Invest 2021; 131(24).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8670840</ArticleId><ArticleId IdType="pubmed">34623973</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobben M, van der Straten K, Brouwer PJ et al. Cross-reactive antibodies after SARS-CoV-2 infection and vaccination. Elife 2021; 10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8610423</ArticleId><ArticleId IdType="pubmed">34812143</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu C, Wang Z, Ren L, et al. Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination. Front Cell Infect Microbiol. 2022;12:978440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9478943</ArticleId><ArticleId IdType="pubmed">36118022</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladner JT, Henson SN, Boyle AS, et al. Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses. Cell Rep Med. 2021;2(1):100189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7816965</ArticleId><ArticleId IdType="pubmed">33495758</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrenz J, Xie Q, Zech F, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination boosts neutralizing activity against Seasonal Human coronaviruses. Clin Infect Dis. 2022;75(1):e653–61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8807272</ArticleId><ArticleId IdType="pubmed">35079775</ArticleId></ArticleIdList></Reference><Reference><Citation>Piret J, Boivin G. Viral interference between respiratory viruses. Emerg Infect Dis. 2022;28(2):273–81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8798701</ArticleId><ArticleId IdType="pubmed">35075991</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>